The formulation of polyhedral boranes for the boron neutron capture therapy of cancer

G. Calabrese; J. Nesnas; Eugen Barbu; D. Fatouros; John Tsibouklis

doi:10.1016/j.drudis.2011.09.014

The formulation of polyhedral boranes for the boron neutron capture therapy of cancer

G. Calabrese
, J. Nesnas
, Eugen Barbu
, D. Fatouros
, John Tsibouklis

Research output: Contribution to journal › Article › peer-review

Abstract

The early promise of boron neutron capture therapy as a method for the treatment of cancer has been inhibited by the inherent toxicity associated with therapeutically useful doses of 10B-containing pharmacophores, the need for target-tissue specificity and the challenges imposed by biological barriers. Although developments in the synthetic chemistry of polyhedral boranes have addressed issues of toxicity to a considerable extent, the optimisation of the transport and the delivery of boronated agents to the site of action – the subject of this review – is a challenge that is addressed by the development of innovative formulation strategies.

Original language	English
Pages (from-to)	153-159
Number of pages	7
Journal	Drug Discovery Today
Volume	17
Issue number	3-4
DOIs	https://doi.org/10.1016/j.drudis.2011.09.014
Publication status	Published - Feb 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.drudis.2011.09.014

Cite this

@article{dc6e8da9dd7b407288f383e61d72bcf1,

title = "The formulation of polyhedral boranes for the boron neutron capture therapy of cancer",

abstract = "The early promise of boron neutron capture therapy as a method for the treatment of cancer has been inhibited by the inherent toxicity associated with therapeutically useful doses of 10B-containing pharmacophores, the need for target-tissue specificity and the challenges imposed by biological barriers. Although developments in the synthetic chemistry of polyhedral boranes have addressed issues of toxicity to a considerable extent, the optimisation of the transport and the delivery of boronated agents to the site of action – the subject of this review – is a challenge that is addressed by the development of innovative formulation strategies.",

author = "G. Calabrese and J. Nesnas and Eugen Barbu and D. Fatouros and John Tsibouklis",

year = "2012",

month = feb,

doi = "10.1016/j.drudis.2011.09.014",

language = "English",

volume = "17",

pages = "153--159",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Limited",

number = "3-4",

}

TY - JOUR

T1 - The formulation of polyhedral boranes for the boron neutron capture therapy of cancer

AU - Calabrese, G.

AU - Nesnas, J.

AU - Barbu, Eugen

AU - Fatouros, D.

AU - Tsibouklis, John

PY - 2012/2

Y1 - 2012/2

N2 - The early promise of boron neutron capture therapy as a method for the treatment of cancer has been inhibited by the inherent toxicity associated with therapeutically useful doses of 10B-containing pharmacophores, the need for target-tissue specificity and the challenges imposed by biological barriers. Although developments in the synthetic chemistry of polyhedral boranes have addressed issues of toxicity to a considerable extent, the optimisation of the transport and the delivery of boronated agents to the site of action – the subject of this review – is a challenge that is addressed by the development of innovative formulation strategies.

AB - The early promise of boron neutron capture therapy as a method for the treatment of cancer has been inhibited by the inherent toxicity associated with therapeutically useful doses of 10B-containing pharmacophores, the need for target-tissue specificity and the challenges imposed by biological barriers. Although developments in the synthetic chemistry of polyhedral boranes have addressed issues of toxicity to a considerable extent, the optimisation of the transport and the delivery of boronated agents to the site of action – the subject of this review – is a challenge that is addressed by the development of innovative formulation strategies.

U2 - 10.1016/j.drudis.2011.09.014

DO - 10.1016/j.drudis.2011.09.014

M3 - Article

SN - 1359-6446

VL - 17

SP - 153

EP - 159

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 3-4

ER -

The formulation of polyhedral boranes for the boron neutron capture therapy of cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this